number treat whatamido epidemiolog pharmacolog number treat nnt epidemiolog measur assess healthcar intervent typic treatment medic nnt number patient treat order prevent addit bad outcom ie reduc expect number case defin endpoint defin invers absolut risk reduct wa describ deriv gener nnt comput respect treatment typic drug placebo eg treatment drug treatment defin endpoint ha specifi eg appear colon cancer fiveyear period probabl pa pb thi endpoint treatment respect nnt comput pb pa relev nnt import measur pharmacoeconom clinic endpoint devast eg death heart attack drug high nnt indic situat endpoint minor health insur declin reimburs drug high nnt exampl statin primari prevent exampl ascotlla manufacturersponsor studi address benefit atorvastatin cholesterol lower drug patient hypertens high blood pressur previou cardiovascular diseas primari prevent trial year dure thi period rel risk primari event heart attack wa reduc absolut risk reduct arr howev wa smaller becaus studi group veri high rate cardiovascular event studi period control group compar treatment group atorvastatin year therefor lead arr onli minu number treat prevent cardiovascular event year work exampl abbrevi variabl equat valu subject control group subject experiment group event control group event experiment group cer control event rate event subject control group eer experiment event rate event subject experiment group arr absolut risk reduct increas cer eer rrr rel risk reduct increas cer eer cer nnt number treat number harm arr rr odd ratio rel risk realli ident articl detail cer eer rel risk odd ratio exampl abov alway risk reduct vice versa number harm convers sideeffect refer laupaci sackett dl robert rs assess clinic measur consequ treatment engl med pmid sever ps dahlf poulter nr al prevent coronari stroke event atorvastatin hypertens patient averag lowerthanaverag cholesterol concentr angloscandinavian cardiac outcom trial lipid lower arm ascotlla multicentr randomis control trial lancet doi pmid bandoli statin ascot updat retriev cholesterol drug ani good busi week retriev that larg clinic studi patient sugar pill placebo heart attack compar patient lipitor number sentenc everi peopl trial year three peopl placebo peopl lipitor heart attack fewer heart attack peopl spare person heart attack peopl lipitor three year measur benefit term littleknown statist number treat nnt person benefit extern link ebem calcul nnt onlin calcul nnt graphpad softwar